Sangamo Therapeutics (SGMOQ) EBIT Margin (2010 - 2025)
Sangamo Therapeutics (SGMOQ) posted EBIT Margin of -268.51% for Q4 2025, up 75.69 percentage points from -344.19% a year earlier and up 5850.77 percentage points from the prior quarter.
Powered by 
Analysis
Sangamo Therapeutics (SGMOQ) EBIT Margin (2010 - 2025) Analysis & Trends
For FY2025, Sangamo Therapeutics' EBIT Margin came in at -306.53%, down 126.65 percentage points from FY2024.
- Annual EBIT Margin shows a five-year change of -196.92 percentage points (FY2020 to FY2025).
- In prior years, Sangamo Therapeutics' EBIT Margin was -179.88% in FY2024 (-24.40 pp), -155.48% in FY2023 (+25.37 pp), -180.85% in FY2022 (-15.23 pp) and -165.61% in FY2021 (-56.00 pp).
- Quarterly EBIT Margin has run from a low of -10712.27% in Q1 2024 to a high of 21.52% in Q3 2024 over five years.
- On a year-over-year basis, EBIT Margin increased in five of the last eight quarters, with an average year-over-year change of -122.21 percentage points.
- The strongest year-over-year quarter for EBIT Margin in the past five years was Q2 2025, with a gain of 10319.32 percentage points; the weakest was Q1 2024, with a drop of 10723.68 percentage points.
- According to Business Quant data, EBIT Margin for the three prior quarters was -6119.28% (Q3 2025), -97.54% (Q2 2025) and -460.28% (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 37.40% |
| 10 | Sangamo Therapeutics | 39.23 Mn | -74.88 Mn | - | -268.51% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -268.51% |
| Sep 30, 2025 | -6,119.28% |
| Jun 30, 2025 | -97.54% |
| Mar 31, 2025 | -460.28% |
| Dec 31, 2024 | -344.19% |
| Sep 30, 2024 | 21.52% |
| Jun 30, 2024 | -10,416.85% |
| Mar 31, 2024 | -10,712.27% |
| Dec 31, 2023 | -3,039.13% |
| Sep 30, 2023 | -1,132.24% |
| Jun 30, 2023 | -1,807.93% |
| Mar 31, 2023 | 11.42% |
| Dec 31, 2022 | -203.42% |
| Sep 30, 2022 | -207.46% |
| Jun 30, 2022 | -155.67% |
| Mar 31, 2022 | -160.32% |
| Dec 31, 2021 | -142.57% |
| Sep 30, 2021 | -169.58% |
| Jun 30, 2021 | -174.73% |
| Mar 31, 2021 | -176.19% |
API Access
Sangamo Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=SGMOQ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "SGMOQ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=SGMOQ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();